ConductScience.org, home

Paper314774

Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.

Neu HC and 3 others. Antimicrob Agents Chemother, 1979. Cited by 196 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds. Papers, record 314774. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/314774

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
196
iCite
Relative citation ratio, by iCite
12.1
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Neu HCH C
2Aswapokee NN
3Fu KPK P
4Aswapokee PP

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CephalosporinsMajor topic
Bacteria
Cefoxitin
Microbial Sensitivity Tests
beta-Lactamases

Source PubMed

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,828,189Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15828189PubMed
215,828,188Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15828188PubMed
3400,937Cefoxitin: an overview of clinical studies in the United States.Rev Infect Dis1979https://conductscience.org/library/papers/400937PubMed
4308,506Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods.J Antimicrob Chemother1978https://conductscience.org/library/papers/308506PubMed
5248,268Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/248268PubMed
6426,518HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/426518PubMed
74,208,895Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4208895PubMed
8783,110The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.J Antimicrob Chemother1976https://conductscience.org/library/papers/783110PubMed

Cited by83

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 196 citations.

PMIDTitleJournalYearIn PapersSource
35,170,719Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.J Antimicrob Chemother2022https://conductscience.org/library/papers/35170719PubMed
34,435,316Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.Paediatr Drugs2021https://conductscience.org/library/papers/34435316PubMed
7,843,824The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years.Infection1994https://conductscience.org/library/papers/7843824PubMed
7,447,408In vitro activity of chloramphenicol and thiamphenicol analogs.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7447408PubMed
7,447,404Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7447404PubMed
7,352,754In vitro studies of 1-oxacephalosporin (LY 127935), a new beta-lactam antibiotic.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7352754PubMed
7,283,419Comparative in vitro study in new cephalosporins.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7283419PubMed
7,247,361Activity of a new cephalosporin antibiotic, Ro 13-9904 against dense populations of selected enterobacteria.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7247361PubMed
7,235,676Klebsiella species: antimicrobial susceptibilities, bactericidal kinetics, and in vitro inactivation of beta-lactam agents.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7235676PubMed
7,114,839Comparative activities of 13 beta-lactam antibiotics.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7114839PubMed
6,995,096The cephalosporins: activity and clinical use.Drugs1980https://conductscience.org/library/papers/6995096PubMed
6,994,640GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6994640PubMed
6,983,857Properties of a new penicillinase type produced by Bacteroides fragilis.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6983857PubMed
6,979,306Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6979306PubMed
6,972,729Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6972729PubMed
6,972,728Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6972728PubMed
6,972,194Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6972194PubMed
6,969,578Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6969578PubMed
6,951,505In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6951505PubMed
6,805,421Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6805421PubMed

See all 83 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/314774

GET https://conductscience.org/api/papers/v1/314774/cited_by?page=2